Peak Love
Release time:
2020-08-14
Peak Love
■ Peak Health Dai Xiaoping
Time flies. In a twinkling of an eye, I have been in Peak for almost 10 years. During this period, I gradually grew up through various training and learning organized by the company, and my continuous experience in various positions. Every post I have experienced has brought me essential experience and harvest in the process of growing up.
The first unit of work at the peak was the Jiangnan plant. When I first entered the factory area, I was stunned by the sight in front of me-the first thing I saw was the delightful rockery, pavilion and artificial lake. The weeping willows by the lake caressed the water surface with the wind. The fish swam happily, sometimes circled, sometimes lined up, sometimes mischievously spitting bubbles. The birds in the trees were singing briskly, and occasionally I could see the imagination of the pine rats in the branches, it is full of sewage and smells sour, but this is a beautiful park.
In 2010 , the powder injection workshop of Jiangnan Factory experienced the upgrading of cefmenoxime production line and the certification of GMP . I was lucky enough to participate in both. During the renovation period, we cleaned up the renovation site every day. Although everyone's work clothes were covered with dust and their faces were like flower cats when they came out of the workshop every day, everyone was happy. The transformation was completed, and after a period of equipment installation and commissioning, the next step was GMP certification. On the day of the certification site audit, the employees participating in the production were all carefully selected and skilled old employees in the workshop. I didn't expect that one of my most junior new employees was also named by the leader. When I know the news, both nervous and happy. When we saw all the equipment and machines start smoothly, and watched the cefmenoxime glass bottles packed according to the specified number of grams being transported orderly along the production line, our mood couldn't help but get excited. Especially after the news of the successful passing of the on-site certification came, some of everyone high-fived each other and some hummed a ditty, because the hard work in the early preparation of the certification was worth it!
2014 6 , because of my yearning for the health care industry, I came to Jianfeng Health Technology Company. Entering a brand-new industry and a brand-new enterprise, it is inevitable for me to encounter some difficulties. Fortunately, the company has special product information, coupled with training and learning, so that I fully understand the characteristics of peak health care products. 2015 1# At the end of February, Peak Health was preparing to open a chain store. Yu Hongjian, then general manager, asked me, "Dai Xiaoping, I heard that you have done sales before. How about transferring you to the health care center?" I am a little unsure, because what I have done before is the sales of clothing products. Are those experiences useful for selling health products? "I'm not familiar with health care products yet. Can there be an adaptation period?" "Yes, I'll give you two months." In this way, I transferred to the Jianfeng Health Center in Shuanglong South Street, and transferred to the newly opened Wuyi Road flagship store in 5 of the same year. The Health Museum is the image window of Jianfeng Health for Jinhua citizens. Our work has also received strong support from company leaders and colleagues. We often go out of the store and go to factories, enterprises and institutions, and street organizations to carry out free lectures on health knowledge and product promotion. The sales laid the foundation. 2016 5 August, I have been in peak health for two years, and I changed my position again to take over the terminal sales business of health care products. 2017 , with the support and help of the company, I successfully completed the annual sales target.
Looking back on the peak year of 10 , there were joys and sorrows and confusion. Although the current development of our peak health is not very ideal, I firmly believe that under the guidance of the enterprise spirit of "unity and struggle, truth-seeking and innovation, determination to rise to the top and climb the peak bravely", the future performance of peak health will be better and better. We will work with other brother units to "create a peak for a hundred years"!
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page